Cefcanel

This classification denotes a cephalosporin antibiotic with the molecular formula C19H18N4O5S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F5V2R6VX8, chemically known as (6r,7r)-7-((r)-mandelamido)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid but generally known as cefcanel, which bears US NIH Compound Identifier 68666. European Medicines Agency schedules Cefcanel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07381MIG. The term CEFCANEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). CEFCANEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cefcanel under HS 29419000 and SITC 54139. As of Q4 2014, CEFCANEL remains the US FDA Preferred Term for this commodity. Cefcanel bears US NLM identifiers UMLS ID C0055001 and NCI Concept Code C76158. SMILES: S1C2N(C(=O)C2NC(=O)C(O)C2CCCCC2)C(=C(C1)CSC1SC(NN1)C)C(=O)O.